Literature DB >> 10953302

Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.

T F Bathen1, T Engan, J Krane, D Axelson.   

Abstract

Human blood plasma samples from 52 subjects were collected and the very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL) and high density lipoprotein were isolated by serial ultra centrifugation. 600 MHz 1H NMR spectra of the lipoprotein fractions were acquired. The methyl and methylene regions in the spectra of VLDL, LDL and HDL were utilised in further analyses via Kohonen neural networks (KNN) and generative topographic mapping (GTM), two related examples of (unsupervised learning) self-organising feature mapping techniques. Systematic variations in lipoprotein profiles can be substantially visualised through the use of KNN and GTM. The relationship between the sample positions in the Kohonen plot was visualised by surface plots of the corresponding VLDL and HDL cholesterol and VLDL triglyceride contents. The GTM maps of the VLDL and HDL fractions were used to investigate the individual properties of selected samples. A large number of the cancer patients were found clustered in the VLDL GTM map, and GTM map positions of samples in relation to CHD, diabetes and renal failure could be found. Although the study group here considered is heterogeneous in respect to age, sex, type of disease and medications within each defined class, classification of VLDL and HDL data with probabilistic neural network (PNN) was quite successful with respect to the groupings: cancer, CHD, volunteers and other (comprising patients with other diseases). Statistics based on 15 independent sets of PNN calculations gave true positive fractions usually higher than 0.83 and false positive fractions lower than 0.088. Attempts to use the corresponding LDL data and four classes were uniformly poor although some classifications (e.g., volunteer versus CHD) were easily performed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953302

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study.

Authors:  Leonardo Tenori; Catherine Oakman; Wederson M Claudino; Patrizia Bernini; Silvia Cappadona; Stefano Nepi; Laura Biganzoli; Michael C Arbushites; Claudio Luchinat; Ivano Bertini; Angelo Di Leo
Journal:  Mol Oncol       Date:  2012-06-01       Impact factor: 6.603

Review 2.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

3.  Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy.

Authors:  Pengxiang Chen; Lihui Han; Cong Wang; Yibin Jia; Qingxu Song; Jianbo Wang; Shanghui Guan; Bingxu Tan; Bowen Liu; Wenqiao Jia; Jianfeng Cui; Wei Zhou; Yufeng Cheng
Journal:  Oncotarget       Date:  2017-06-20

4.  Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study.

Authors:  Piero Del Boccio; Francesca Perrotti; Claudia Rossi; Ilaria Cicalini; Sara Di Santo; Mirco Zucchelli; Paolo Sacchetta; Domenico Genovesi; Damiana Pieragostino
Journal:  Adv Radiat Oncol       Date:  2017-01-05

Review 5.  Metabolomics, a New Promising Technology for Toxicological Research.

Authors:  Kyu-Bong Kim; Byung Mu Lee
Journal:  Toxicol Res       Date:  2009-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.